Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line

Prostate

Volumn 55, Issue 1, 2003, Pages 9-19

  Christiansen, Jason J ^a   Rajasekaran, Sigrid A ^a   Moy, Peggy ^b   Butch, Anthony ^a   Goodglick, Lee ^a   Gu, Zhennan ^a   Reiter, Robert E ^a   Bander, Neil H ^b   Rajasekaran, Ayyappan K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Prostate; Prostate neoplasm; Prostate specific antigen; Prostate specific membrane antigen; Prostate stem cell antigen; Protein targeting

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE STEM CELL ANTIGEN;

ANIMAL CELL; ARTICLE; BIOASSAY; BIOTINYLATION; CELL CULTURE; CELL LINE; CELL MEMBRANE; CELL SURFACE; CONFOCAL MICROSCOPY; EPITHELIUM CELL; EVALUATION; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; INTERNALIZATION; MODEL; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TARGETING;

ANIMALS; ANTIGENS, SURFACE; BIOTINYLATION; CARBOXYPEPTIDASES; CELL LINE; CELL MEMBRANE; CELL POLARITY; DOGS; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; NEOPLASM PROTEINS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRANSFECTION;

EID: 0037382951     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10203     Document Type: Article

References (45)

1. Simons K, Wandinger-Ness A. Polarized sorting in epithelia. Cell 1990;62:207-210.
2. Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol 1963;17:375-412.
3. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7:927-935.
4. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 1998;95:1735-1740.
5. Lundwall A, Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett 1987;214:317-322.
6. Vihko P, Virkkunen P, Henttu P, Roiko K, Solin T, Huhtala ML. Molecular cloning and sequence analysis of cDNA encoding human prostatic acid phosphatase. FEBS Lett 1988;236:275-281.
7. Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC, Madraswala R, Zhou Y, Kuo J, Raitano AB, Jakobovits A, Saffran DC, Afar DE. STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci USA 1999;96:14523-14528.
8. Carter RE, Feldman AR, Coyle JT. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci USA 1996;93:749-753.
9. Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May F, Mukherjee B, Heston WD. Prostate-specific membrane antigen: A novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 1996;2:1445-1451.
10. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997;3:81-85.
11. Sweat SD, Pacelli A, Murphy GP, Bostwick DG. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology 1998;52:637-640.
12. Wright GL, Jr., Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, Troyer J, Konchuba A, Schellhammer PF, Moriarty R. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 1996;48:326-334.
13. Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 1999;59:3192-3198.
14. Chang SS, O'Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 1999;5:2674-2681.
15. Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V, Knudsen B, Bander NH. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res 1997;57:3629-3634.
16. Elgamal AA, Holmes EH, Su SL, Tino WT, Simmons SJ, Peterson M, Greene TG, Boynton AL, Murphy GP. Prostate-specific membrane antigen (PSMA): Current benefits and future value. Semin Surg Oncol 2000;18:10-16.
17. Gu Z, Thomas G, Yamashiro J, Shintaku IP, Dorey F, Raitano A, Witte ON, Said JW, Loda M, Reiter RE. Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage, and bone metastasis in prostate cancer. Oncogene 2000;19:1288-1296.
18. Saffran DC, Raitano AB, Hubert RS, Witte ON, Reiter RE, Jakobovits A. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci USA 2001;98:2658-2663.
19. Saffran DC, Reiter RE, Jakobovits A, Witte ON. Target antigens for prostate cancer immunotherapy. Cancer Metastasis Rev 1999;18:437-449.
20. Kuriyama M, Wang MC, Lee CI, Papsidero LD, Killian CS, Inaji H, Slack NH, Nishiura T, Murphy GP, Chu TM. Use of human prostate. Cancer Res 1981;41:3874-3876.
21. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer [published erratum appears in N Engl J Med 1991 Oct 31; 325(18):1324] [see comments]. N Engl J Med 1991;324:1156-1161.
22. Ban Y, Wang MC, Watt KW, Loor R, Chu TM. The proteolytic activity of human prostate-specific antigen. Biochem Biophys Res Commun 1984;123:482-488.
23. Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 1997;57:3111-3114.
24. Christensson A, Lilja H. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur J Biochem 1994;220:45-53.
25. Webber MM, Waghray A, Bello D. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1995;1:1089-1094.
26. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76:1899-1903.
27. Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM. A prostate antigen in sera of prostatic cancer patients. Cancer Res 1980;40:2428-2432.
28. Tuma PL, Finnegan CM, Yi JH, Hubbard AL. Evidence for apical endocytosis in polarized hepatic cells: Phosphoinositide 3-kinase inhibitors lead to the lysosomal accumulation of resident apical plasma membrane proteins. J Cell Biol 1999;145:1089-1102.
29. Sun AQ, Ananthanarayanan M, Soroka CJ, Thevananther S, Shneider BL, Suchy FJ. Sorting of rat liver and ileal sodium-dependent bile acid transporters in polarized epithelial cells. Am J Physiol 1998;275:G1045-1055.
30. Nussenzveig DR, Matos MD, Thaw CN. Human calcitonin receptor is directly targeted to and retained in the basolateral surface of MDCK cells. Am J Physiol 1998;275:C1264-1276.
31. Lipardi C, Nitsch L, Zurzolo C. Mechanisms of apical protein sorting in polarized thyroid epithelial cells. Biochimie 1999;81:347-353.
32. Prabakaran D, Ahima RS, Harney JW, Berry MJ, Larsen PR, Arvan P. Polarized targeting of epithelial cell proteins in thyrocytes and MDCK cells. J Cell Sci 1999;112:1247-1256.
33. Eldering JA, Grünberg J, Hahn D, Croes HJ, Fransen JA, Sterchi EE. Polarised expression of human intestinal N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase (human meprin) alpha and beta subunits in Madin-Darby canine kidney cells. Eur J Biochem 1997;247:920-932.
34. Delgrossi MH, Breuza L, Mirre C, Chavrier P, Le Bivic A. Human syntaxin 3 is localized apically in human intestinal cells. J Cell Sci 1997;110:2207-2214.
35. Rajasekaran AK, Humphrey JS, Wagner M, Miesenböck G, Le Bivic A, Bonifacino JS, Rodriguez-Boulan E. TGN38 recycles basolaterally in polarized Madin-Darby canine kidney cells. Mol Biol Cell 1994;5:1093-1103.
36. Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball WJ, Jr., Bander NH, Peralta Soler A, Rajasekaran AK. Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell 2001;12:279-295.
37. Gonzalez-Mariscal L, Chávez de Ramírez B, Cereijido M. Tight junction formation in cultured epithelial cells (MDCK). J Membr Biol 1985;86:113-125.
38. Liu H, Rajasekaran AK, Moy P, Xia Y, Kim S, Navarro V, Rahmati R, Bander NH. Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res 1998;58:4055-4060.
39. Rodriguez-Boulan E, Powell SK. Polarity of epithelial and neuronal cells. Annu Rev Cell Biol 1992;8:395-427.
40. Matter K, Mellman I. Mechanisms of cell polarity: Sorting and transport in epithelial cells. Curr Opin Cell Biol 1994;6:545-554.
41. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 1990;87:4246-4250.
42. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-572.
43. Killian CS, Corral DA, Kawinski E, Constantine RI. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 1993;192:940-947.
44. Cohen P, Peehl DM, Graves HC, Rosenfeld RG. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 1994;142:407-415.
45. Vessey CJ, Wilding J, Folarin N, Hirano S, Takeichi M, Soutter P, Stamp GW, Pignatelli M. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 1995;176:151-159.